Acuity Software for Autism Spectrum Disorder

N/A

Waitlist Available

Research Sponsored by Experiad LLC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at the end of the study, expected to be 18 months from the start of retroactive observation period

Awards & highlights

No Placebo-Only Group

Summary

This trial will test improvements to a software used for collecting data during behavioral therapy sessions. The software will now have a new tool called Acuity, which is designed to help Behavior Analysts and Behavior Techn

Who is the study for?

This trial is for Behavior Analysts (BAs) and Behavior Technicians (BTs) who use the Motivity software in their practice. It's aimed at those working with individuals with Autism Spectrum Disorder to improve behavioral therapy delivery.

What is being tested?

The study is evaluating Acuity, a new clinical decision support module within the Motivity software. This Quality Improvement intervention is designed to enhance how BAs and BTs collect data and make decisions during autism behavioral therapy.

What are the potential side effects?

Since this trial involves a software feature enhancement rather than a medical treatment, traditional side effects are not applicable. However, users may experience challenges adapting to new features or technical issues.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at the end of the study, expected to be 18 months from the start of retroactive observation period

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at the end of the study, expected to be 18 months from the start of retroactive observation period

This trial's timeline: 3 weeks for screening, Varies for treatment, and at the end of the study, expected to be 18 months from the start of retroactive observation period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Frequency at which Acuity and its components are rated as suitable, fitting, or proper for achieving the goals set forth in treatment plans, as measured by surveys.

Increased adherence to prescribed dosage

Increased frequency of changes to programs and prescribed dosages, resulting in reduced Trials to Criterion and Time to Criterion.

+5 more